TP53 Gene Changes in Melanoma
Author Information
Author(s): V.A. Florenes, T. 0yjord, R. Holm, M. Skrede, A.-L. B0rresen, J.M. Nesland, 0. Fodstad
Primary Institution: The Norwegian Radium Hospital
Hypothesis
What is the role of TP53 gene alterations in malignant melanoma?
Conclusion
The study found that TP53 gene alterations are not significantly involved in the tumorigenesis of malignant melanoma.
Supporting Evidence
- TP53 gene aberrations were found in 7 of 30 patients.
- Six patients showed loss of heterozygosity.
- Point mutations were detected in only two cases.
- Patients with superficial spreading melanoma and positive p53 protein expression had a longer relapse-free period.
Takeaway
Researchers looked at the DNA of melanoma patients to see if changes in a gene called TP53 were causing the cancer, but they found it wasn't a major factor.
Methodology
The study analyzed tumor samples from 30 melanoma patients for TP53 gene alterations and protein expression.
Limitations
The study had a limited sample size and focused only on specific exons of the TP53 gene.
Participant Demographics
Patients with malignant melanoma, including various histological subtypes.
Statistical Information
P-Value
0.03
Statistical Significance
p=0.03
Want to read the original?
Access the complete publication on the publisher's website